Cho Cindy Sun-Yan, Lim Kevin, Siu Ivan Chi-Hin, Ho Jacky Yan-Kit, Chow Simon Chi-Ying, Fujikawa Takuya, Kwok Micky Wai-Ting, Wong Randolph Hung-Leung
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales Hospital, Hong Kong, China.
J Thorac Dis. 2025 Apr 30;17(4):2662-2678. doi: 10.21037/jtd-2024-2041. Epub 2025 Apr 27.
Despite modern advancements, infective endocarditis remains a devastating disease with high mortality and morbidity rates. Given the heterogeneous patient background and the complexity of the condition, the decision for surgery is difficult. Traditional general cardiac surgery risk models, including EuroSCORE and Society of Thoracic Surgeons (STS) score, do not include disease-specific factors that often impact both the operability and frailty of patients. The aim of the study is to review the strength and limitations of current risk scores designed specifically for patients with infective endocarditis.
A search in PubMed and OVID databases was conducted for articles and abstracts published from inception to 1 June 2024 using the terms "infective endocarditis" AND "risk score" or "surgical futility" or "operative mortality".
Various risk scores have therefore been developed to help stratify the operative risks of these patients by incorporating endocarditis-specific features. This review aims to analyse the applicability and usefulness of risk scores in the setting of surgical management of infective endocarditis, which in turn helps to identify patients who would benefit from interventions. From 2007, a total of 18 risk scores have been designed specifically for patients with infective endocarditis. These scores however have low generalisability since different patient characteristics, disease factors and validation strategies are used. In various validation cohorts and comparative studies, the discrimination performances of these scores are unsatisfactory. Most of the studies focused on early, or in-patient mortality, while the intermediate and long-term mortality was not well studied.
Risk stratification for the group of patients who are indicated for surgery, but only received medical treatment due to perceived futility or were too unstable to proceed to operation, is pertinent. This population is not frequently recruited to current studies, and more research is needed.
尽管有现代医学的进步,但感染性心内膜炎仍然是一种具有高死亡率和发病率的毁灭性疾病。鉴于患者背景的异质性和病情的复杂性,手术决策很困难。传统的一般心脏手术风险模型,包括欧洲心脏手术风险评估系统(EuroSCORE)和胸外科医师协会(STS)评分,并不包括那些经常影响患者可手术性和虚弱程度的疾病特异性因素。本研究的目的是回顾专门为感染性心内膜炎患者设计的当前风险评分的优势和局限性。
在PubMed和OVID数据库中进行检索,使用“感染性心内膜炎 ”和“风险评分”或“手术无意义”或“手术死亡率”等术语,检索从数据库建立到2024年6月1日发表的文章和摘要。
因此,已经开发了各种风险评分,通过纳入心内膜炎特异性特征来帮助对这些患者的手术风险进行分层。本综述旨在分析风险评分在感染性心内膜炎手术管理中的适用性和实用性,这反过来有助于识别将从干预中受益的患者。自2007年以来,总共设计了18种专门针对感染性心内膜炎患者的风险评分。然而,由于使用了不同的患者特征、疾病因素和验证策略,这些评分的通用性较低。在各种验证队列和比较研究中,这些评分的鉴别性能并不理想。大多数研究关注早期或住院死亡率,而中期和长期死亡率没有得到很好的研究。
对于那些被建议进行手术,但由于认为手术无意义而仅接受药物治疗或因过于不稳定而无法进行手术的患者群体,进行风险分层是有必要的。这一人群在当前研究中并不经常被纳入,因此需要更多的研究。